ANKRD44 Antibodies

Santa Cruz Biotechnology offers a broad range of ANKRD44 monoclonal antibodies for research applications. ANKRD44 monoclonal antibodies are validated for multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ANKRD44, or Ankyrin Repeat Domain 44, plays a crucial role in cellular processes such as signal transduction and protein-protein interactions. Understanding ANKRD44 function is vital for unraveling cellular mechanisms and disease states. Research involving ANKRD44 continues to reveal new insights into cancer development and immune system regulation. ANKRD44 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. Advanced research techniques using ANKRD44 monoclonal antibodies help identify potential therapeutic targets and biomarkers. Ongoing studies of ANKRD44 contribute to expanding knowledge of cellular signaling networks and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.